Evaluation of synergetic anticancer activity of berberine and curcumin on different models of A549, Hep-G2, MCF-7, Jurkat, and K562 cell lines

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Balakrishna, Acharya ^a   Kumar, M Hemanth ^a  

^a Patanjali Yog Peeth Trust Hardwar   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; CURCUMIN; DIMETHYL SULFOXIDE; FORMAZAN; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL LINE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; DRUG SCREENING; HUMAN; HUMAN CELL; CELL SURVIVAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECTS; HEP-G2 CELL LINE; JURKAT CELL LINE; K-562 CELL LINE; MCF-7 CELL LINE; NEOPLASMS, EXPERIMENTAL; PATHOLOGY; TREATMENT OUTCOME;

BERBERIS ARISTATA; CURCUMA LONGA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BERBERINE; CELL SURVIVAL; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HEP G2 CELLS; HUMANS; JURKAT CELLS; K562 CELLS; MCF-7 CELLS; NEOPLASMS, EXPERIMENTAL; TREATMENT OUTCOME;

EID: 84937022165     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/354614     Document Type: Article

References (15)

1. G. M. Cragg, D. J. Newman, and K. M. Snader, "Natural products in drug discovery and development," Journal of Natural Products, vol. 60, no. 1, pp. 52-60, 1997.
2. S. Gupta, D. Zhang, J. Yi, and J. Shao, "Anticancer activities of Oldenlandia diffusa," Journal of Herbal Pharmacotherapy, vol. 4, no. 1, pp. 21-33, 2004.
3. M. H. Kumar, V. Dhiman, R. Choudhary, and A. Chikara, "Anticancer activity of hydroalcoholic extracts from Paris polyphylla rhizomes against human A549 lung cancer cell lines usingMTT assay," International Research Journal of Pharmacy, vol. 5, no. 4, pp. 290-294, 2014.
4. J. K. Tiwari, R. Ballabha, and P. Tiwari, "Ethnopaediatrics in garhwal himalaya uttarkhand india (psychomedicine and medicine)," New York Science Journal, vol. 3, no. 4, pp. 123-126, 2010.
5. The Ayurvedic Pharmacopoeia of India, vol. 2, Government of India, Ministry of Health and Family Welfare Department of AYUSH, New Delhi, India, 2007.
6. M. Imanshahidi and H. Hosseinzadeh, "Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine," Phytotherapy Research, vol. 22, no. 8, pp. 999-1012, 2008.
7. K. Inoue, U. Kulsum, S. A. Chowdhury et al., "Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines," Anticancer Research, vol. 25, no. 6, pp. 4053-4059, 2005.
8. I. N. Dobelis, Ed., Magic and Medicine of Plants, Reader's Digest Association, Pleasantville, NY, USA, 1986.
9. A. Leung, Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics, vol. 13, JohnWiley & Sons, New York, NY, USA, 1980.
10. B. B. Aggarwal, A. Kumar, and A.C. Bharti, "Anticancer potential of curcumin: preclinical and clinical studies," Anticancer Research, vol. 23, no. 1, pp. 363-398, 2003.
11. R. A. Sharma, A. J. Gescher, and W. P. Steward, "Curcumin: the story so far," European Journal of Cancer, vol. 41,no. 13,pp. 1955- 1968, 2005.
12. B. Wahlstromand G. Blennow, "A study on the fate of curcumin in the rat,"Acta Pharmacologica et Toxicologica, vol. 43,no. 2, pp. 86-92, 1978.
13. V. Ravindranath and N. Chandrasekhara, "Absorption and tissue distribution of curcumin in rats," Toxicology, vol. 16, no. 3, pp. 259-265, 1980.
14. S. Toda, T. Miyase, H. Arichi, H. Tanizawa, and Y. Takino, "Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa L," Chemical and Pharmaceutical Bulletin, vol. 33, no. 4, pp. 1725-1728, 1985.
15. M. Dikshit, L. Rastogi, R. Shukla, and R. C. Srimal, "Prevention of ischaemia-induced biochemical changes by curcumin and quinidine in the cat heart," Indian Journal of Medical Research, vol. 101, pp. 31-35, 1995.